This is a table of type unigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| unigram | frequency |
|---|---|
| sars | 170593 |
| cov | 145995 |
| covid | 110576 |
| patients | 89311 |
| coronavirus | 65443 |
| infection | 56313 |
| virus | 51214 |
| respiratory | 46440 |
| disease | 45103 |
| viral | 41854 |
| protein | 41392 |
| cells | 39081 |
| severe | 37058 |
| clinical | 35290 |
| study | 34920 |
| also | 32882 |
| human | 32580 |
| may | 31208 |
| acute | 29606 |
| syndrome | 28418 |
| cell | 27657 |
| ace | 27127 |
| using | 25881 |
| cases | 25364 |
| data | 25086 |
| health | 24639 |
| treatment | 22649 |
| rna | 22240 |
| associated | 21444 |
| novel | 21154 |
| used | 20804 |
| analysis | 20792 |
| studies | 20487 |
| based | 20263 |
| high | 20105 |
| infected | 19926 |
| two | 19758 |
| risk | 19588 |
| transmission | 19384 |
| reported | 18551 |
| binding | 18018 |
| one | 18001 |
| time | 17867 |
| positive | 17522 |
| china | 17473 |
| results | 17350 |
| however | 17062 |
| immune | 16797 |
| potential | 16751 |
| receptor | 16659 |
| symptoms | 16520 |
| pandemic | 16454 |
| patient | 16167 |
| response | 16063 |
| use | 15951 |
| i | 15813 |
| case | 15684 |
| proteins | 15634 |
| first | 15097 |
| control | 15062 |
| samples | 14782 |
| including | 14612 |
| different | 14573 |
| care | 14431 |
| spike | 14411 |
| viruses | 14283 |
| pneumonia | 14251 |
| outbreak | 14113 |
| days | 14034 |
| pcr | 13977 |
| infections | 13939 |
| specific | 13887 |
| new | 13773 |
| expression | 13729 |
| found | 13378 |
| host | 13282 |
| well | 13272 |
| among | 13259 |
| table | 13239 |
| system | 13109 |
| lung | 13062 |
| mers | 13060 |
| number | 12970 |
| antibody | 12856 |
| antibodies | 12389 |
| review | 12314 |
| influenza | 12179 |
| detection | 11956 |
| anti | 11704 |
| test | 11687 |
| related | 11618 |
| will | 11598 |
| non | 11513 |
| activity | 11463 |
| hospital | 11456 |
| higher | 11437 |
| testing | 11351 |
| drug | 11296 |
| due | 11249 |
| coronaviruses | 11145 |
| shown | 11056 |
| showed | 11050 |
| available | 11020 |
| like | 11002 |
| vaccine | 10976 |
| levels | 10810 |
| il | 10707 |
| group | 10700 |
| role | 10667 |
| inflammatory | 10455 |
| three | 10377 |
| diseases | 10367 |
| structure | 10280 |
| observed | 10262 |
| antiviral | 10201 |
| negative | 10167 |
| compared | 10159 |
| type | 10117 |
| early | 10039 |
| infectious | 9993 |
| evidence | 9943 |
| wuhan | 9896 |
| authors | 9806 |
| increased | 9646 |
| preprint | 9644 |
| performed | 9634 |
| cord | 9619 |
| model | 9594 |
| rate | 9494 |
| replication | 9464 |
| blood | 9436 |
| drugs | 9401 |
| population | 9386 |
| cd | 9380 |
| important | 9347 |
| within | 9317 |
| rt | 9303 |
| spread | 9289 |
| molecular | 9257 |
| mortality | 9213 |
| research | 9140 |
| several | 9115 |
| gene | 9113 |
| low | 9111 |
| doi | 9093 |
| responses | 9022 |
| identified | 8958 |
| possible | 8957 |
| effects | 8924 |
| development | 8860 |
| nsp | 8816 |
| significant | 8811 |
| key | 8760 |
| confirmed | 8752 |
| although | 8648 |
| factors | 8570 |
| assay | 8523 |
| similar | 8507 |
| therefore | 8417 |
| many | 8414 |
| sequence | 8374 |
| genome | 8372 |
| public | 8353 |
| day | 8328 |
| therapy | 8257 |
| children | 8252 |
| acid | 8250 |
| entry | 8200 |
| age | 8199 |
| characteristics | 8178 |
| effect | 8112 |
| present | 8016 |
| individuals | 7953 |
| igg | 7942 |
| medical | 7936 |
| without | 7814 |
| angiotensin | 7768 |
| ncov | 7729 |
| single | 7686 |
| addition | 7667 |
| findings | 7637 |
| protease | 7597 |
| might | 7564 |
| target | 7555 |
| report | 7506 |
| lower | 7480 |
| epidemic | 7463 |
| known | 7422 |
| date | 7404 |
| rbd | 7399 |
| pro | 7383 |
| information | 7336 |
| level | 7256 |
| tested | 7255 |
| effective | 7236 |
| contact | 7227 |
| inhibitors | 7217 |
| diagnosis | 7202 |
| enzyme | 7175 |
| world | 7109 |
| mice | 7078 |
| following | 7075 |
| ml | 7072 |
| asymptomatic | 6996 |
| induced | 6980 |
| laboratory | 6968 |
| multiple | 6921 |
| function | 6900 |
| membrane | 6894 |
| people | 6885 |
| large | 6885 |
| current | 6839 |
| recent | 6817 |
| detected | 6751 |
| tests | 6742 |
| total | 6702 |
| medrxiv | 6681 |
| sample | 6659 |
| since | 6651 |
| respectively | 6622 |
| structural | 6620 |
| serum | 6603 |
| domain | 6590 |
| common | 6545 |
| global | 6543 |
| countries | 6537 |
| years | 6529 |
| likely | 6522 |
| therapeutic | 6499 |
| site | 6495 |
| surface | 6389 |
| considered | 6378 |
| described | 6349 |
| increase | 6347 |
| activation | 6317 |
| highly | 6311 |
| cytokine | 6281 |
| license | 6197 |
| interaction | 6167 |
| rapid | 6166 |
| features | 6159 |
| sequences | 6123 |
| caused | 6116 |
| management | 6088 |
| via | 6087 |
| onset | 6069 |
| fever | 6058 |
| even | 6048 |
| period | 6010 |
| outcomes | 5998 |
| complex | 5993 |
| injury | 5974 |
| critical | 5968 |
| changes | 5945 |
| developed | 5913 |
| journal | 5912 |
| pulmonary | 5910 |
| measures | 5901 |
| id | 5898 |
| vaccines | 5892 |
| impact | 5886 |
| humans | 5868 |
| small | 5862 |
| ct | 5858 |
| significantly | 5857 |
| need | 5800 |
| vitro | 5783 |
| severity | 5762 |
| presence | 5760 |
| genes | 5753 |
| included | 5746 |
| residues | 5730 |
| healthcare | 5707 |
| cancer | 5704 |
| en | 5702 |
| plasma | 5698 |
| death | 5651 |
| ii | 5637 |
| less | 5634 |
| tissue | 5625 |
| cause | 5624 |
| immunity | 5614 |
| factor | 5607 |
| result | 5566 |
| international | 5561 |
| inflammation | 5555 |
| methods | 5534 |
| long | 5513 |
| given | 5495 |
| mild | 5478 |
| another | 5472 |
| ifn | 5466 |
| obtained | 5462 |
| prevention | 5462 |
| interactions | 5400 |
| models | 5360 |
| groups | 5331 |
| production | 5314 |
| version | 5309 |
| provide | 5299 |
| approach | 5285 |
| major | 5234 |
| collected | 5231 |
| orf | 5225 |
| exposure | 5223 |
| mediated | 5223 |
| hiv | 5202 |
| four | 5189 |
| work | 5171 |
| fusion | 5149 |
| trial | 5134 |
| middle | 5123 |
| previously | 5107 |
| screening | 5106 |
| according | 5106 |
| phase | 5102 |
| required | 5096 |
| inhibitor | 5088 |
| efficacy | 5085 |
| main | 5083 |
| made | 5082 |
| conditions | 5056 |
| value | 5043 |
| hospitalized | 5042 |
| illness | 5037 |
| support | 5019 |
| range | 5018 |
| assays | 5004 |
| mechanisms | 4972 |
| author | 4950 |
| whether | 4943 |
| values | 4933 |
| animal | 4915 |
| isolation | 4913 |
| workers | 4907 |
| copyright | 4898 |
| demonstrated | 4895 |
| emerging | 4887 |
| pathogenesis | 4883 |
| diagnostic | 4866 |
| trials | 4828 |
| active | 4827 |
| cohort | 4816 |
| region | 4803 |
| inhibition | 4802 |
| initial | 4795 |
| method | 4786 |
| cellular | 4781 |
| mg | 4766 |
| dna | 4763 |
| per | 4756 |
| title | 4752 |
| protective | 4742 |
| dependent | 4728 |
| amino | 4724 |
| previous | 4721 |
| species | 4720 |
| failure | 4718 |
| various | 4716 |
| east | 4668 |
| co | 4664 |
| general | 4662 |
| community | 4660 |
| currently | 4635 |
| mechanism | 4619 |
| sensitivity | 4616 |
| still | 4606 |
| recently | 4594 |
| doc | 4576 |
| sha | 4573 |
| uid | 4571 |
| mutations | 4554 |
| expressed | 4551 |
| compounds | 4543 |
| display | 4537 |
| state | 4536 |
| th | 4474 |
| tract | 4424 |
| prevalence | 4416 |
| rates | 4410 |
| direct | 4396 |
| https | 4392 |
| interferon | 4391 |
| neutralizing | 4390 |
| specimens | 4379 |
| process | 4368 |
| course | 4362 |
| include | 4358 |
| identification | 4355 |
| tmprss | 4318 |
| hcov | 4315 |
| reports | 4312 |
| limited | 4304 |
| association | 4284 |
| cytokines | 4272 |
| air | 4271 |
| involved | 4269 |
| functional | 4243 |
| bat | 4241 |
| standard | 4215 |
| hydroxychloroquine | 4214 |
| treated | 4177 |
| damage | 4174 |
| especially | 4173 |
| differences | 4173 |
| march | 4171 |
| converting | 4170 |
| primary | 4166 |
| least | 4156 |
| safety | 4153 |
| second | 4149 |
| sites | 4145 |
| suggest | 4139 |
| family | 4135 |
| dose | 4131 |
| cross | 4120 |
| post | 4102 |
| future | 4087 |
| additional | 4081 |
| show | 4064 |
| peptide | 4050 |
| states | 4045 |
| protection | 4045 |
| revealed | 4025 |
| design | 4023 |
| national | 4015 |
| deaths | 4015 |
| glycoprotein | 4009 |
| either | 4001 |
| granted | 3993 |
| order | 3991 |
| reaction | 3982 |
| org | 3974 |
| distribution | 3965 |
| emergency | 3963 |
| article | 3962 |
| reduce | 3955 |
| antigen | 3954 |
| reduced | 3952 |
| load | 3951 |
| mm | 3933 |
| form | 3930 |
| min | 3926 |
| el | 3916 |
| systems | 3908 |
| strategies | 3897 |
| remdesivir | 3890 |
| containing | 3890 |
| funder | 3885 |
| receptors | 3882 |
| followed | 3870 |
| essential | 3850 |
| prevent | 3845 |
| genetic | 3839 |
| systematic | 3838 |
| us | 3836 |
| regions | 3831 |
| admission | 3830 |
| across | 3812 |
| epithelial | 3802 |
| overall | 3798 |
| suggested | 3788 |
| adults | 3780 |
| published | 3777 |
| chest | 3777 |
| igm | 3776 |
| polymerase | 3773 |
| chinese | 3770 |
| mean | 3769 |
| agents | 3762 |
| presented | 3761 |
| liver | 3760 |
| targeting | 3758 |
| evaluation | 3755 |
| moreover | 3738 |
| concentration | 3735 |
| staff | 3722 |
| animals | 3719 |
| social | 3718 |
| chronic | 3716 |
| distress | 3711 |
| pathway | 3711 |
| identify | 3704 |
| kidney | 3701 |
| structures | 3657 |
| heart | 3653 |
| organization | 3650 |
| normal | 3648 |
| affected | 3646 |
| real | 3640 |
| holder | 3636 |
| targets | 3631 |
| chloroquine | 3625 |
| epidemiological | 3623 |
| dynamics | 3621 |
| swab | 3615 |
| particles | 3594 |
| set | 3589 |
| furthermore | 3585 |
| women | 3584 |
| events | 3584 |
| approved | 3584 |
| example | 3581 |
| diabetes | 3557 |
| combination | 3546 |
| perpetuity | 3545 |
| term | 3545 |
| natural | 3538 |
| individual | 3528 |
| secondary | 3512 |
| provided | 3507 |
| history | 3502 |
| must | 3499 |
| understanding | 3488 |
| derived | 3475 |
| innate | 3473 |
| full | 3469 |
| pre | 3462 |
| close | 3453 |
| guidelines | 3452 |
| mouse | 3450 |
| brain | 3445 |
| lead | 3437 |
| chain | 3431 |
| ventilation | 3413 |
| complications | 3410 |
| signaling | 3406 |
| temperature | 3405 |
| analyses | 3399 |
| comparison | 3392 |
| determined | 3386 |
| types | 3384 |
| suspected | 3379 |
| manifestations | 3379 |
| implications | 3373 |
| needed | 3358 |
| local | 3353 |
| convalescent | 3351 |
| hong | 3346 |
| icu | 3345 |
| genomic | 3342 |
| epitopes | 3340 |
| outcome | 3339 |
| five | 3337 |
| isolated | 3331 |
| docking | 3326 |
| molecules | 3326 |
| ill | 3324 |
| analyzed | 3322 |
| point | 3322 |
| times | 3316 |
| posted | 3315 |
| shows | 3303 |
| retrospective | 3300 |
| conducted | 3299 |
| united | 3298 |
| sequencing | 3297 |
| size | 3289 |
| outbreaks | 3288 |
| cardiovascular | 3277 |
| center | 3273 |
| covs | 3272 |
| mutation | 3267 |
| better | 3257 |
| swabs | 3247 |
| surveillance | 3247 |
| origin | 3245 |
| cough | 3226 |
| ards | 3223 |
| person | 3215 |
| develop | 3212 |
| kong | 3207 |
| indicated | 3201 |
| see | 3199 |
| series | 3198 |
| transcription | 3197 |
| peer | 3188 |
| open | 3184 |
| regarding | 3176 |
| despite | 3167 |
| symptomatic | 3162 |
| specificity | 3149 |
| release | 3140 |
| symptom | 3138 |
| knowledge | 3137 |
| strategy | 3136 |
| biological | 3132 |
| area | 3125 |
| lungs | 3121 |
| selected | 3118 |
| areas | 3115 |
| lopinavir | 3112 |
| pathways | 3107 |
| network | 3105 |
| assessment | 3100 |
| free | 3099 |
| pathogens | 3096 |
| bats | 3094 |
| hand | 3093 |
| status | 3092 |
| suggesting | 3090 |
| life | 3087 |
| resulting | 3071 |
| part | 3068 |
| nasopharyngeal | 3068 |
| affinity | 3066 |
| inhibit | 3061 |
| recombinant | 3057 |
| predicted | 3055 |
| cluster | 3054 |
| prior | 3048 |
| april | 3044 |
| weeks | 3042 |
| year | 3040 |
| interest | 3034 |
| worldwide | 3027 |
| reduction | 3026 |
| nucleic | 3023 |
| around | 3013 |
| rapidly | 3013 |
| particularly | 3000 |
| procedures | 2998 |
| seen | 2997 |
| storm | 2994 |
| energy | 2989 |
| literature | 2989 |
| potentially | 2987 |
| room | 2984 |
| whereas | 2984 |
| cleavage | 2982 |
| much | 2981 |
| help | 2981 |
| healthy | 2973 |
| supplementary | 2969 |
| suggests | 2964 |
| old | 2962 |
| determine | 2959 |
| water | 2957 |
| defined | 2956 |
| leading | 2953 |
| median | 2952 |
| able | 2948 |
| organ | 2943 |
| endothelial | 2942 |
| particular | 2940 |
| nucleocapsid | 2936 |
| elevated | 2932 |
| directly | 2932 |
| epidemiology | 2931 |
| consistent | 2930 |
| evolution | 2926 |
| short | 2914 |
| lack | 2896 |
| nasal | 2896 |
| cardiac | 2891 |
| oxygen | 2879 |
| hepatitis | 2879 |
| now | 2874 |
| reverse | 2872 |
| step | 2872 |
| alveolar | 2865 |
| taken | 2860 |
| recommended | 2858 |
| ritonavir | 2852 |
| characterization | 2850 |
| change | 2848 |
| vs | 2843 |
| intensive | 2843 |
| critically | 2840 |
| average | 2839 |
| often | 2836 |
| generated | 2836 |
| oral | 2829 |
| culture | 2827 |
| evaluated | 2826 |
| hospitals | 2821 |
| incidence | 2821 |
| end | 2814 |
| tissues | 2805 |
| medicine | 2804 |
| subjects | 2803 |
| causes | 2803 |
| remains | 2801 |
| protocol | 2799 |
| yet | 2797 |
| line | 2794 |
| increasing | 2789 |
| incubation | 2788 |
| difference | 2783 |
| experimental | 2770 |
| score | 2769 |
| received | 2761 |
| peptides | 2761 |
| participants | 2758 |
| months | 2757 |
| ci | 2756 |
| basis | 2756 |
| responsible | 2753 |
| elisa | 2751 |
| body | 2748 |
| systemic | 2743 |
| se | 2740 |
| terminal | 2739 |
| upper | 2738 |
| der | 2738 |
| recommendations | 2735 |
| macrophages | 2735 |
| stage | 2733 |
| contacts | 2724 |
| experience | 2719 |
| collection | 2718 |
| quality | 2716 |
| estimated | 2714 |
| greater | 2714 |
| ability | 2707 |
| length | 2707 |
| personal | 2706 |
| activities | 2699 |
| unit | 2698 |
| necessary | 2690 |
| populations | 2688 |
| mainly | 2687 |
| vero | 2679 |
| formation | 2674 |
| con | 2672 |
| six | 2671 |
| discovery | 2663 |
| later | 2650 |
| proposed | 2649 |
| pathogen | 2646 |
| administration | 2641 |
| genomes | 2638 |
| neurological | 2633 |
| moderate | 2627 |
| hypertension | 2626 |
| meta | 2625 |
| quarantine | 2616 |
| follow | 2606 |
| droplets | 2601 |
| involvement | 2596 |
| usa | 2596 |
| concentrations | 2593 |
| dysfunction | 2592 |
| reference | 2585 |
| nm | 2578 |
| fact | 2575 |
| potent | 2572 |
| scale | 2571 |
| self | 2567 |
| decreased | 2565 |
| complete | 2565 |
| italy | 2564 |
| cc | 2562 |
| university | 2556 |
| treatments | 2554 |
| appropriate | 2552 |
| ratio | 2551 |
| absence | 2549 |
| source | 2545 |
| los | 2542 |
| face | 2540 |
| relatively | 2537 |
| strong | 2536 |
| contrast | 2535 |
| loss | 2533 |
| investigation | 2532 |
| detect | 2530 |
| certified | 2529 |
| strains | 2528 |
| relative | 2528 |
| indicate | 2527 |
| together | 2524 |
| masks | 2523 |
| cl | 2520 |
| randomized | 2520 |
| finally | 2518 |
| home | 2517 |
| adult | 2515 |
| stress | 2514 |
| recovery | 2514 |
| controlled | 2513 |
| agent | 2510 |
| cdc | 2505 |
| already | 2504 |
| progression | 2504 |
| hospitalization | 2497 |
| ligand | 2486 |
| expected | 2483 |
| database | 2481 |
| linked | 2475 |
| infect | 2475 |
| hours | 2462 |
| pressure | 2461 |
| central | 2461 |
| susceptibility | 2461 |
| applied | 2457 |
| admitted | 2456 |
| added | 2455 |
| exposed | 2451 |
| whole | 2451 |
| strain | 2449 |
| next | 2440 |
| parameters | 2432 |
| correlation | 2432 |
| relevant | 2431 |
| aerosol | 2423 |
| older | 2413 |
| calculated | 2412 |
| scientific | 2405 |
| importance | 2403 |
| properties | 2402 |
| flow | 2402 |
| ph | 2395 |
| best | 2394 |
| context | 2392 |
| produced | 2389 |
| performance | 2386 |
| indicating | 2383 |
| unknown | 2378 |
| along | 2378 |
| approximately | 2374 |
| rights | 2372 |
| vaccination | 2371 |
| vivo | 2359 |
| sera | 2356 |
| criteria | 2352 |
| independent | 2351 |
| become | 2349 |
| conserved | 2341 |
| rdrp | 2340 |
| recognition | 2338 |
| environmental | 2338 |
| occurred | 2335 |
| pregnant | 2329 |
| imaging | 2328 |
| members | 2325 |
| ab | 2320 |
| variants | 2316 |
| fold | 2312 |
| gastrointestinal | 2308 |
| die | 2308 |
| tnf | 2307 |
| pathogenic | 2305 |
| occur | 2303 |
| synthesis | 2302 |
| underlying | 2300 |
| approaches | 2298 |
| terms | 2298 |
| developing | 2296 |
| serological | 2295 |
| comorbidities | 2295 |
| highest | 2292 |
| play | 2290 |
| induce | 2288 |
| airway | 2287 |
| third | 2286 |
| reactive | 2283 |
| www | 2283 |
| possibility | 2278 |
| regulation | 2278 |
| far | 2277 |
| daily | 2276 |
| renal | 2276 |
| recovered | 2271 |
| situation | 2271 |
| numbers | 2270 |
| decrease | 2267 |
| established | 2267 |
| envelope | 2263 |
| causing | 2260 |
| shedding | 2256 |
| practice | 2256 |
| ongoing | 2256 |
| acids | 2251 |
| neutralization | 2250 |
| require | 2248 |
| mrna | 2246 |
| side | 2243 |
| travel | 2242 |
| final | 2242 |
| duration | 2239 |
| others | 2232 |
| surgical | 2230 |
| therapies | 2230 |
| million | 2223 |
| index | 2223 |
| action | 2221 |
| pediatric | 2221 |
| capacity | 2221 |
| note | 2219 |
| allowed | 2218 |
| equipment | 2215 |
| vascular | 2215 |
| unique | 2210 |
| amplification | 2206 |
| reserved | 2202 |
| nc | 2202 |
| manuscript | 2201 |
| adverse | 2200 |
| access | 2198 |
| designed | 2196 |
| hydrogen | 2196 |
| controls | 2190 |
| broad | 2177 |
| ebola | 2177 |
| signs | 2171 |
| interestingly | 2170 |
| monoclonal | 2168 |
| combined | 2160 |
| existing | 2158 |
| challenge | 2158 |
| spectrum | 2153 |
| week | 2153 |
| functions | 2148 |
| beta | 2144 |
| clinically | 2141 |
| environment | 2136 |
| clear | 2135 |
| proportion | 2131 |
| bind | 2126 |
| experiments | 2125 |
| mask | 2123 |
| nature | 2121 |
| additionally | 2117 |
| dimer | 2117 |
| probable | 2116 |
| provides | 2113 |
| delivery | 2112 |
| corresponding | 2109 |
| susceptible | 2107 |
| persons | 2107 |
| subsequent | 2105 |
| presentation | 2098 |
| majority | 2095 |
| surfaces | 2092 |
| growth | 2087 |
| signal | 2085 |
| oc | 2084 |
| measured | 2084 |
| statistical | 2084 |
| material | 2080 |
| emergence | 2076 |
| products | 2074 |
| good | 2074 |
| pattern | 2072 |
| und | 2070 |
| settings | 2068 |
| wide | 2062 |
| stability | 2061 |
| nucleotide | 2061 |
| monitoring | 2060 |
| setting | 2059 |
| peripheral | 2054 |
| assessed | 2053 |
| assess | 2050 |
| inhibits | 2050 |
| titers | 2043 |
| way | 2038 |
| proteases | 2038 |
| survival | 2034 |
| prediction | 2030 |
| increases | 2024 |
| february | 2022 |
| affect | 2021 |
| frequency | 2020 |
| position | 2019 |
| efficient | 2019 |
| society | 2017 |
| improved | 2008 |
| saliva | 2007 |
| tool | 2006 |
| diagnosed | 2005 |
| stem | 2002 |
| department | 2002 |
| late | 2001 |
| variables | 1999 |
| buffer | 1997 |
| rather | 1994 |
| solution | 1992 |
| incubated | 1990 |
| concern | 1988 |
| resulted | 1986 |
| specifically | 1983 |
| epitope | 1982 |
| investigated | 1982 |
| relationship | 1981 |
| kit | 1981 |
| search | 1979 |
| mechanical | 1978 |
| medium | 1978 |
| characterized | 1978 |
| contribute | 1974 |
| pregnancy | 1973 |
| evaluate | 1972 |
| subunit | 1970 |
| disorders | 1970 |
| cycle | 1963 |
| improve | 1961 |
| application | 1956 |
| bacterial | 1951 |
| pathology | 1950 |
| physical | 1946 |
| distinct | 1945 |
| candidate | 1944 |
| simulation | 1942 |
| treat | 1939 |
| male | 1936 |
| stroke | 1933 |
| obesity | 1932 |
| volume | 1932 |
| infectivity | 1931 |
| media | 1929 |
| software | 1929 |
| last | 1922 |
| guidance | 1918 |
| qpcr | 1916 |
| january | 1913 |
| limit | 1911 |
| generation | 1909 |
| understand | 1906 |
| patterns | 1906 |
| crucial | 1905 |
| false | 1901 |
| studied | 1901 |
| ribavirin | 1897 |
| useful | 1896 |
| mass | 1896 |
| molecule | 1886 |
| noted | 1885 |
| paper | 1882 |
| forms | 1881 |
| olfactory | 1881 |
| fatality | 1880 |
| city | 1879 |
| ppe | 1876 |
| promising | 1875 |
| remain | 1874 |
| sensitive | 1872 |
| nd | 1872 |
| transplant | 1871 |
| subsequently | 1868 |
| hcq | 1868 |
| enhanced | 1865 |
| airborne | 1865 |
| expressing | 1861 |
| activated | 1859 |
| fluid | 1858 |
| challenges | 1858 |
| resources | 1856 |
| december | 1855 |
| panel | 1853 |
| domains | 1852 |
| interventions | 1850 |
| diarrhea | 1848 |
| supported | 1847 |
| alpha | 1845 |
| wild | 1842 |
| province | 1838 |
| residue | 1838 |
| iii | 1838 |
| though | 1837 |
| del | 1836 |
| class | 1835 |
| indeed | 1835 |
| complexes | 1833 |
| european | 1831 |
| poor | 1829 |
| carried | 1829 |
| double | 1826 |
| represent | 1826 |
| similarly | 1822 |
| certain | 1821 |
| bound | 1819 |
| ns | 1817 |
| generally | 1815 |
| reviewed | 1812 |
| led | 1810 |
| sampling | 1809 |
| multi | 1805 |
| hence | 1802 |
| lymphocytes | 1797 |
| singapore | 1795 |
| efforts | 1794 |
| surgery | 1793 |
| make | 1793 |
| targeted | 1793 |
| technology | 1791 |
| died | 1790 |
| apoptosis | 1785 |
| sex | 1783 |
| induces | 1781 |
| summary | 1781 |
| benefit | 1781 |
| coagulation | 1781 |
| crisis | 1781 |
| usually | 1780 |
| induction | 1777 |
| emerged | 1775 |
| country | 1774 |
| myocardial | 1769 |
| alternative | 1767 |
| effectiveness | 1764 |
| selection | 1761 |
| processing | 1759 |
| considering | 1759 |
| antigens | 1758 |
| centers | 1756 |
| hku | 1756 |
| resistance | 1755 |
| condition | 1752 |
| route | 1748 |
| interleukin | 1746 |
| young | 1745 |
| government | 1744 |
| finding | 1740 |
| quantitative | 1737 |
| light | 1734 |
| peak | 1734 |
| fatal | 1731 |
| influence | 1729 |
| science | 1728 |
| reducing | 1728 |
| stable | 1727 |
| alone | 1726 |
| primer | 1724 |
| fda | 1724 |
| preliminary | 1720 |
| lines | 1719 |
| means | 1718 |
| leads | 1718 |
| phylogenetic | 1718 |
| indicates | 1717 |
| elderly | 1715 |
| avoid | 1713 |
| un | 1712 |
| event | 1709 |
| substrate | 1707 |
| seven | 1704 |
| transport | 1704 |
| crystal | 1700 |
| every | 1698 |
| survey | 1697 |
| widely | 1696 |
| team | 1694 |
| done | 1692 |
| organs | 1689 |
| versus | 1685 |
| mental | 1684 |
| none | 1683 |
| aged | 1683 |
| towards | 1681 |
| li | 1681 |
| making | 1680 |
| insights | 1678 |
| candidates | 1678 |
| past | 1676 |
| compound | 1675 |
| observational | 1675 |
| hcws | 1673 |
| count | 1673 |
| outside | 1670 |
| contain | 1669 |
| located | 1668 |
| zoonotic | 1668 |
| difficult | 1668 |
| thrombosis | 1666 |
| nl | 1664 |
| lymphocyte | 1660 |
| components | 1659 |
| purified | 1659 |
| seems | 1658 |
| safe | 1654 |
| processes | 1653 |
| hla | 1651 |
| procedure | 1650 |
| por | 1649 |
| requires | 1646 |
| resolution | 1643 |
| contains | 1642 |
| working | 1641 |
| acquired | 1639 |
| services | 1632 |
| consider | 1632 |
| frequently | 1632 |
| uk | 1631 |
| right | 1625 |
| examined | 1623 |
| june | 1623 |
| predict | 1623 |
| avian | 1621 |
| examination | 1621 |
| commonly | 1619 |
| serious | 1618 |
| appears | 1616 |
| clearance | 1616 |
| mol | 1614 |
| allow | 1611 |
| profile | 1608 |
| copies | 1608 |
| risks | 1608 |
| almost | 1607 |
| membranes | 1606 |
| field | 1605 |
| needs | 1603 |
| throat | 1599 |
| distance | 1598 |
| called | 1594 |
| vector | 1592 |
| donors | 1591 |
| intervention | 1590 |
| binds | 1589 |
| wang | 1588 |
| isolates | 1587 |
| longer | 1586 |
| inhibitory | 1586 |
| left | 1586 |
| prognosis | 1582 |
| hr | 1582 |
| droplet | 1581 |
| researchers | 1580 |
| specimen | 1580 |
| hypothesis | 1575 |
| live | 1575 |
| reporting | 1573 |
| presenting | 1573 |
| kinase | 1571 |
| ang | 1571 |
| pdb | 1570 |
| online | 1570 |
| efficiency | 1566 |
| des | 1566 |
| transmitted | 1565 |
| protected | 1561 |
| modeling | 1561 |
| stages | 1559 |
| top | 1559 |
| throughout | 1558 |
| providing | 1556 |
| chemical | 1555 |
| focus | 1555 |
| precautions | 1555 |
| reveals | 1553 |
| pbs | 1552 |
| correlated | 1550 |
| complement | 1548 |
| clusters | 1548 |
| extraction | 1545 |
| take | 1542 |
| protect | 1541 |
| md | 1541 |
| sepsis | 1540 |
| lesions | 1540 |
| requiring | 1539 |
| larger | 1537 |
| initially | 1537 |
| red | 1536 |
| fibrosis | 1536 |
| occurs | 1534 |
| density | 1531 |
| simulations | 1530 |
| food | 1530 |
| similarity | 1528 |
| iga | 1527 |
| half | 1524 |
| threat | 1524 |
| conformation | 1521 |
| consensus | 1520 |
| extracted | 1516 |
| laboratories | 1515 |
| includes | 1513 |
| circulating | 1512 |
| proven | 1509 |
| place | 1509 |
| distancing | 1505 |
| program | 1504 |
| corticosteroids | 1504 |
| protocols | 1503 |
| markers | 1501 |
| tools | 1497 |
| prepared | 1497 |
| memory | 1497 |
| prospective | 1493 |
| limitations | 1493 |
| points | 1493 |
| prolonged | 1490 |
| improvement | 1490 |
| loop | 1489 |
| tlr | 1488 |
| weight | 1488 |
| household | 1487 |
| find | 1483 |
| strongly | 1481 |
| variation | 1477 |
| repurposing | 1475 |
| effectively | 1473 |
| tocilizumab | 1471 |
| background | 1468 |
| economic | 1466 |
| transmembrane | 1465 |
| block | 1465 |
| variable | 1465 |
| enzymes | 1463 |
| facilities | 1462 |
| interval | 1462 |
| modified | 1461 |
| produce | 1460 |
| attention | 1460 |
| earlier | 1455 |
| germany | 1451 |
| appear | 1450 |
| therapeutics | 1449 |
| questions | 1448 |
| personnel | 1445 |
| declare | 1443 |
| adaptive | 1441 |
| preventing | 1440 |
| discharge | 1438 |
| fully | 1437 |
| showing | 1437 |
| epidemics | 1437 |
| ms | 1436 |
| represents | 1434 |
| treating | 1433 |
| conclusion | 1433 |
| pathological | 1432 |
| primers | 1432 |
| probably | 1432 |
| assembly | 1431 |
| units | 1431 |
| routine | 1429 |
| maximum | 1428 |
| articles | 1426 |
| basic | 1426 |
| contamination | 1424 |
| platform | 1424 |
| committee | 1423 |
| generate | 1422 |
| pacientes | 1421 |
| percentage | 1417 |
| closely | 1415 |
| south | 1415 |
| bond | 1409 |
| men | 1408 |
| frequent | 1408 |
| inactivated | 1407 |
| discussed | 1405 |
| thank | 1402 |
| regulatory | 1400 |
| encephalitis | 1400 |
| typical | 1399 |
| pain | 1395 |
| comparative | 1395 |
| lessons | 1394 |
| log | 1394 |
| detailed | 1394 |
| estimate | 1391 |
| demonstrate | 1389 |
| consequences | 1388 |
| urgent | 1388 |
| core | 1388 |
| nervous | 1385 |
| np | 1384 |
| zinc | 1383 |
| issues | 1383 |
| administered | 1380 |
| great | 1378 |
| investigate | 1378 |
| europe | 1375 |
| recognized | 1375 |
| hosts | 1372 |
| seroprevalence | 1370 |
| para | 1370 |
| extensive | 1369 |
| involving | 1365 |
| amount | 1362 |
| cost | 1361 |
| fc | 1359 |
| azithromycin | 1357 |
| clearly | 1354 |
| possibly | 1352 |
| reuse | 1351 |
| macrophage | 1348 |
| significance | 1348 |
| morbidity | 1346 |
| degree | 1345 |
| implemented | 1344 |
| permission | 1342 |
| aspects | 1342 |
| aerosols | 1338 |
| reactivity | 1338 |
| receiving | 1337 |
| commercial | 1337 |
| extent | 1337 |
| institute | 1337 |
| explain | 1336 |
| accuracy | 1333 |
| unclear | 1333 |
| interface | 1332 |
| ic | 1332 |
| section | 1327 |
| csf | 1326 |
| american | 1325 |
| diversity | 1325 |
| product | 1324 |
| newly | 1324 |
| observations | 1323 |
| comprehensive | 1323 |
| probability | 1322 |
| stat | 1321 |
| documented | 1320 |
| blocking | 1319 |
| computational | 1317 |
| scores | 1317 |
| measure | 1317 |
| notably | 1317 |
| little | 1316 |
| estimates | 1315 |
| robust | 1313 |
| lockdown | 1313 |
| psychological | 1312 |
| ca | 1311 |
| alignment | 1310 |
| original | 1310 |
| von | 1309 |
| ensure | 1307 |
| hydrophobic | 1307 |
| materials | 1304 |
| inhibiting | 1304 |
| preparation | 1304 |
| sense | 1304 |
| sufficient | 1303 |
| intracellular | 1303 |
| dr | 1301 |
| options | 1300 |
| validation | 1299 |
| observation | 1295 |
| doses | 1294 |
| availability | 1294 |
| cns | 1291 |
| spreading | 1291 |
| las | 1289 |
| variety | 1288 |
| continuous | 1288 |
| electron | 1284 |
| focused | 1281 |
| primarily | 1281 |
| declared | 1280 |
| tumor | 1280 |
| eight | 1278 |
| shock | 1276 |
| just | 1276 |
| steps | 1276 |
| murine | 1275 |
| account | 1273 |
| female | 1272 |
| kcal | 1269 |
| stranded | 1269 |
| corona | 1267 |
| regression | 1267 |
| hubei | 1266 |
| evolutionary | 1265 |
| particle | 1265 |
| substantial | 1264 |
| diagnostics | 1261 |
| decision | 1260 |
| conformational | 1259 |
| wastewater | 1258 |
| contributed | 1258 |
| lipid | 1258 |
| remained | 1256 |
| update | 1254 |
| furin | 1254 |
| recombination | 1254 |
| catalytic | 1253 |
| intravenous | 1253 |
| st | 1252 |
| sputum | 1252 |
| motif | 1249 |
| serine | 1248 |
| disinfection | 1247 |
| detectable | 1247 |
| act | 1247 |
| matrix | 1245 |
| facilitate | 1244 |
| clpro | 1243 |
| humoral | 1242 |
| lamp | 1240 |
| started | 1239 |
| biology | 1239 |
| nevertheless | 1238 |
| perspective | 1237 |
| intermediate | 1236 |
| bias | 1232 |
| except | 1228 |
| titer | 1228 |
| threshold | 1227 |
| depends | 1227 |
| silico | 1227 |
| view | 1227 |
| promote | 1225 |
| korea | 1225 |
| invasive | 1224 |
| nk | 1224 |
| employed | 1223 |
| immunoglobulin | 1223 |
| identifying | 1222 |
| july | 1221 |
| plays | 1221 |
| infants | 1221 |
| bonds | 1220 |
| western | 1219 |
| images | 1218 |
| mostly | 1217 |
| roles | 1216 |
| nf | 1215 |
| ranging | 1214 |
| http | 1213 |
| mpro | 1213 |
| india | 1213 |
| proinflammatory | 1212 |
| monocytes | 1212 |
| stool | 1208 |
| released | 1208 |
| fast | 1204 |
| uses | 1204 |
| immunization | 1204 |
| consent | 1204 |
| space | 1203 |
| neutrophil | 1201 |
| variant | 1200 |
| axis | 1199 |
| renin | 1198 |
| nuclear | 1198 |
| reactions | 1198 |
| green | 1197 |
| figures | 1196 |
| nine | 1195 |
| chen | 1194 |
| special | 1194 |
| perform | 1194 |
| baseline | 1193 |
| taking | 1189 |
| disorder | 1189 |
| discharged | 1188 |
| epithelium | 1187 |
| differential | 1187 |
| beneficial | 1187 |
| concerns | 1186 |
| metabolic | 1185 |
| microscopy | 1185 |
| driven | 1183 |
| named | 1182 |
| hace | 1182 |
| map | 1180 |
| became | 1180 |
| techniques | 1180 |
| lethal | 1180 |
| immunological | 1179 |
| toxicity | 1178 |
| policy | 1178 |
| ray | 1177 |
| mutant | 1177 |
| confirm | 1176 |
| practices | 1176 |
| nan | 1174 |
| fecal | 1172 |
| importantly | 1172 |
| optimal | 1169 |
| accurate | 1168 |
| dilution | 1168 |
| transfer | 1167 |
| exhibited | 1167 |
| preventive | 1166 |
| describe | 1166 |
| anxiety | 1164 |
| progress | 1164 |
| traditional | 1163 |
| ha | 1162 |
| asthma | 1162 |
| profiles | 1161 |
| sources | 1161 |
| entire | 1160 |
| typically | 1160 |
| zhang | 1159 |
| inactivation | 1157 |
| likelihood | 1157 |
| plus | 1156 |
| counts | 1155 |
| nurses | 1155 |
| mentioned | 1154 |
| publication | 1153 |
| informed | 1152 |
| necrosis | 1150 |
| dynamic | 1150 |
| les | 1149 |
| month | 1149 |
| hygiene | 1148 |
| kg | 1148 |
| benefits | 1145 |
| ocular | 1142 |
| mode | 1141 |
| simple | 1139 |
| statistically | 1139 |
| plates | 1138 |
| identity | 1138 |
| york | 1137 |
| beyond | 1136 |
| tree | 1135 |
| soluble | 1133 |
| enhance | 1131 |
| homology | 1131 |
| flu | 1130 |
| dataset | 1130 |
| successful | 1129 |
| neutrophils | 1128 |
| cultures | 1128 |
| maternal | 1126 |
| quickly | 1126 |
| learning | 1125 |
| white | 1122 |
| relationships | 1122 |
| minutes | 1121 |
| thereby | 1120 |
| deep | 1120 |
| loads | 1117 |
| intubation | 1114 |
| glass | 1113 |
| continue | 1111 |
| extended | 1111 |
| excluded | 1111 |
| dengue | 1109 |
| validated | 1107 |
| recorded | 1107 |
| ng | 1107 |
| etc | 1107 |
| advanced | 1106 |
| fetal | 1106 |
| autophagy | 1105 |
| muscle | 1105 |
| capable | 1104 |
| isolate | 1103 |
| know | 1102 |
| probe | 1100 |
| whose | 1099 |
| true | 1099 |
| library | 1098 |
| manner | 1098 |
| thought | 1098 |
| macaques | 1097 |
| ground | 1097 |
| besides | 1097 |
| routes | 1097 |
| diverse | 1096 |
| supporting | 1096 |
| bilateral | 1096 |
| taiwan | 1095 |
| vulnerable | 1095 |
| skin | 1094 |
| barrier | 1093 |
| ec | 1092 |
| force | 1092 |
| nosocomial | 1092 |
| platelet | 1091 |
| descriptive | 1090 |
| funding | 1090 |
| abnormalities | 1089 |
| sets | 1088 |
| metabolism | 1088 |
| stay | 1087 |
| numerous | 1086 |
| conflict | 1086 |
| mitochondrial | 1085 |
| una | 1084 |
| intestinal | 1084 |
| plasmid | 1084 |
| enveloped | 1083 |
| appeared | 1082 |
| completely | 1081 |
| agreement | 1081 |
| lymphopenia | 1080 |
| washed | 1077 |
| dry | 1077 |
| recipients | 1076 |
| african | 1076 |
| taste | 1075 |
| africa | 1074 |
| interact | 1074 |
| mammalian | 1074 |
| extracellular | 1073 |
| base | 1072 |
| fluorescence | 1071 |
| reduces | 1071 |
| algorithm | 1070 |
| allows | 1069 |
| burden | 1068 |
| blocked | 1068 |
| le | 1067 |
| comparing | 1067 |
| feature | 1067 |
| cold | 1067 |
| removed | 1066 |
| resistant | 1066 |
| es | 1066 |
| syncytial | 1064 |
| address | 1064 |
| serve | 1064 |
| applications | 1063 |
| synthetic | 1063 |
| diluted | 1062 |
| er | 1062 |
| temporal | 1061 |
| headache | 1061 |
| regard | 1059 |
| vitamin | 1058 |
| adequate | 1057 |
| dendritic | 1057 |
| investigations | 1056 |
| list | 1056 |
| problems | 1054 |
| linear | 1054 |
| em | 1054 |
| classified | 1054 |
| largely | 1053 |
| fragment | 1053 |
| shared | 1053 |
| directed | 1048 |
| putative | 1046 |
| web | 1046 |
| experienced | 1046 |
| screened | 1044 |
| survivors | 1044 |
| achieved | 1044 |
| ser | 1044 |
| smoking | 1044 |
| widespread | 1043 |
| neonatal | 1042 |
| confidence | 1041 |
| instead | 1041 |
| random | 1039 |
| immediately | 1038 |
| content | 1037 |
| nct | 1037 |
| com | 1037 |
| component | 1035 |
| sd | 1035 |
| reasons | 1033 |
| label | 1033 |
| living | 1032 |
| school | 1030 |
| remaining | 1030 |
| ligands | 1029 |
| formed | 1027 |
| express | 1027 |
| transfected | 1026 |
| latter | 1023 |
| throughput | 1022 |
| cryo | 1021 |
| beginning | 1021 |
| translation | 1021 |
| reveal | 1020 |
| conclusions | 1019 |
| obtain | 1017 |
| italian | 1016 |
| aim | 1016 |
| server | 1015 |
| clinicians | 1011 |
| immunogenicity | 1010 |
| regulated | 1009 |
| physicians | 1009 |
| link | 1008 |
| cq | 1007 |
| market | 1007 |
| dyspnea | 1005 |
| near | 1004 |
| institutional | 1003 |
| globally | 1000 |
| problem | 1000 |
| positivity | 999 |
| medications | 999 |
| coverage | 999 |
| placed | 998 |
| computed | 998 |
| centre | 998 |
| encoding | 998 |
| suitable | 997 |
| atypical | 997 |
| continued | 995 |
| inhibited | 995 |
| facility | 994 |
| abnormal | 994 |
| professionals | 993 |
| implementation | 993 |
| betacoronavirus | 991 |
| selective | 991 |
| question | 990 |
| heat | 990 |
| transferred | 990 |
| tracing | 989 |
| turn | 989 |
| france | 989 |
| share | 989 |
| reason | 988 |
| comparable | 987 |
| nursing | 986 |
| toward | 985 |
| displayed | 984 |
| delayed | 984 |
| pp | 983 |
| males | 982 |
| bacteria | 981 |
| autoimmune | 979 |
| cys | 979 |
| breath | 977 |
| rhesus | 976 |
| discovered | 975 |
| asia | 975 |
| glycosylation | 975 |
| curve | 973 |
| training | 972 |
| depending | 971 |
| demographic | 970 |
| mixed | 970 |
| blue | 969 |
| fragments | 969 |
| contained | 969 |
| financial | 968 |
| canada | 968 |
| anosmia | 968 |
| cats | 967 |
| dental | 965 |
| child | 965 |
| secretion | 964 |
| occurrence | 964 |
| exact | 964 |
| liu | 964 |
| fatigue | 964 |
| gold | 963 |
| successfully | 962 |
| subject | 962 |
| rare | 960 |
| irf | 959 |
| compare | 958 |
| interpretation | 957 |
| details | 957 |
| twice | 956 |
| transplantation | 955 |
| reads | 955 |
| colleagues | 954 |
| heparin | 953 |
| enhancement | 953 |
| occurring | 953 |
| mhv | 950 |
| lineage | 949 |
| plate | 949 |
| classification | 948 |
| statement | 947 |
| pandemics | 947 |
| toronto | 946 |
| gender | 944 |
| communication | 944 |
| cdna | 944 |
| immunodeficiency | 943 |
| immunosuppression | 943 |
| attachment | 942 |
| reliable | 942 |
| antigenic | 942 |
| mother | 941 |
| biorxiv | 940 |
| networks | 940 |
| head | 940 |
| ibd | 939 |
| persistent | 938 |
| option | 938 |
| autopsy | 938 |
| mit | 938 |
| read | 938 |
| vital | 938 |
| universal | 938 |
| diffuse | 936 |
| smell | 936 |
| sodium | 935 |
| eye | 935 |
| efficiently | 935 |
| member | 934 |
| respect | 933 |
| impaired | 933 |
| mothers | 933 |
| crp | 932 |
| ten | 932 |
| wearing | 932 |
| seasonal | 930 |
| cysteine | 930 |
| strand | 929 |
| technologies | 927 |
| writing | 926 |
| interests | 925 |
| met | 923 |
| fit | 923 |
| represented | 923 |
| chemokines | 923 |
| respirators | 922 |
| relation | 922 |
| serial | 921 |
| reproduction | 920 |
| resource | 920 |
| kits | 920 |
| follows | 920 |
| start | 918 |
| seem | 917 |
| contaminated | 917 |
| internal | 917 |
| detecting | 917 |
| largest | 917 |
| spain | 916 |
| ion | 915 |
| cumulative | 915 |
| attenuated | 915 |
| framework | 914 |
| japan | 914 |
| fixed | 914 |
| rsv | 914 |
| reading | 914 |
| venous | 913 |
| summarized | 913 |
| starting | 912 |
| issue | 912 |
| predictive | 912 |
| papain | 912 |
| minimum | 911 |
| separate | 909 |
| plpro | 908 |
| nearly | 908 |
| highlighted | 908 |
| clade | 907 |
| mucosal | 907 |
| corticosteroid | 906 |
| instance | 906 |
| ivig | 905 |
| aging | 905 |
| overview | 904 |
| phosphate | 904 |
| modelling | 904 |
| representative | 903 |
| screen | 902 |
| serology | 901 |
| thrombotic | 901 |
| approval | 901 |
| marker | 899 |
| aids | 898 |
| staining | 898 |
| definition | 897 |
| coding | 897 |
| regional | 897 |
| iv | 897 |
| maintain | 897 |
| constant | 896 |
| distributed | 896 |
| minimal | 895 |
| severely | 895 |
| gov | 894 |
| repeated | 894 |
| september | 894 |
| usage | 893 |
| controlling | 893 |
| automated | 892 |
| virtual | 891 |
| easily | 891 |
| project | 889 |
| favipiravir | 889 |
| divided | 888 |
| altered | 886 |
| donor | 886 |
| integrated | 885 |
| supply | 884 |
| oropharyngeal | 884 |
| utilized | 883 |
| containment | 882 |
| impairment | 882 |
| america | 882 |
| reservoir | 881 |
| behavior | 880 |
| hcv | 880 |
| antivirals | 880 |
| placebo | 879 |
| residents | 878 |
| consideration | 878 |
| competing | 878 |
| younger | 878 |
| channel | 877 |
| purification | 876 |
| families | 875 |
| inpatients | 875 |
| tropism | 875 |
| ward | 874 |
| domestic | 872 |
| datasets | 872 |
| man | 871 |
| virulence | 870 |
| outpatient | 868 |
| technique | 868 |
| policies | 868 |
| interim | 868 |
| composition | 868 |
| encoded | 867 |
| indirect | 867 |
| image | 866 |
| signals | 865 |
| degradation | 865 |
| identical | 864 |
| guide | 864 |
| 864 | |
| nt | 864 |
| enter | 863 |
| rooms | 863 |
| reached | 863 |
| smaller | 862 |
| affecting | 861 |
| variations | 861 |
| mutants | 861 |
| proliferation | 861 |
| west | 860 |
| localization | 859 |
| closed | 859 |
| biochemical | 859 |
| urine | 859 |
| august | 859 |
| ethical | 859 |
| fraction | 859 |
| clinic | 859 |
| nodes | 859 |
| pl | 856 |
| interstitial | 855 |
| consequently | 855 |
| conventional | 854 |
| designated | 853 |
| exhibit | 852 |
| template | 852 |
| prophylaxis | 851 |
| authorities | 851 |
| accepted | 851 |
| seq | 851 |
| enough | 850 |
| estimation | 850 |
| positions | 849 |
| otherwise | 848 |
| inclusion | 848 |
| platforms | 848 |
| service | 847 |
| optimized | 847 |
| toll | 847 |
| bei | 847 |
| cultured | 847 |
| attack | 845 |
| intensity | 845 |
| stimulated | 845 |
| actions | 844 |
| neurologic | 844 |
| immediate | 844 |
| mscs | 843 |
| proper | 842 |
| apparent | 841 |
| virion | 841 |
| considerations | 841 |
| gel | 840 |
| saudi | 839 |
| proteolytic | 839 |
| adjusted | 838 |
| cm | 838 |
| run | 838 |
| capture | 837 |
| visits | 837 |
| coagulopathy | 837 |
| vertical | 837 |
| created | 837 |
| inflammasome | 837 |
| virions | 836 |
| nlrp | 836 |
| allowing | 836 |
| yang | 836 |
| arterial | 836 |
| origins | 835 |
| depression | 834 |
| sharing | 834 |
| makes | 833 |
| contribution | 832 |
| inside | 831 |
| hour | 831 |
| humidity | 831 |
| supplemental | 830 |
| records | 830 |
| guangdong | 830 |
| aimed | 830 |
| maintained | 829 |
| van | 828 |
| activate | 828 |
| mir | 828 |
| replicase | 827 |
| psychiatric | 827 |
| neonates | 827 |
| sub | 826 |
| adenovirus | 824 |
| partial | 824 |
| carriers | 823 |
| go | 823 |
| differentiation | 823 |
| expert | 823 |
| glucose | 823 |
| always | 822 |
| location | 822 |
| persistence | 821 |
| education | 821 |
| involves | 819 |
| interesting | 818 |
| assessing | 818 |
| interacting | 818 |
| biomarkers | 818 |
| publications | 817 |
| processed | 817 |
| hcovs | 817 |
| generating | 816 |
| secretions | 816 |
| iqr | 816 |
| repeat | 815 |
| gloves | 815 |
| mixture | 815 |
| mouth | 815 |
| reach | 813 |
| oxidative | 812 |
| ethics | 812 |
| associations | 812 |
| reflect | 810 |
| plant | 810 |
| establish | 809 |
| programs | 808 |
| recommend | 808 |
| proteinase | 808 |
| coronaviridae | 808 |
| coronary | 808 |
| rnas | 808 |
| introduction | 806 |
| back | 806 |
| exist | 805 |
| slightly | 805 |
| briefly | 804 |
| initiation | 804 |
| pathogenicity | 803 |
| vomiting | 803 |
| defense | 802 |
| gisaid | 802 |
| rmsd | 800 |
| lu | 800 |
| parallel | 800 |
| vesicles | 800 |
| dpp | 799 |
| circulation | 799 |
| construct | 798 |
| periods | 797 |
| uv | 796 |
| lancet | 796 |
| phenotype | 796 |
| column | 796 |
| deletion | 795 |
| arthritis | 795 |
| eine | 794 |
| cut | 794 |
| bone | 794 |
| ras | 793 |
| profiling | 793 |
| characteristic | 793 |
| myocarditis | 793 |
| eventually | 792 |
| helicase | 792 |
| namely | 791 |
| achieve | 791 |
| explore | 791 |
| frame | 790 |
| performing | 790 |
| predominantly | 790 |
| washing | 789 |
| solid | 788 |
| monitored | 788 |
| analysed | 787 |
| beijing | 786 |
| pooled | 786 |
| infiltration | 786 |
| nose | 786 |
| females | 786 |
| wu | 785 |
| ed | 785 |
| extremely | 785 |
| suppression | 785 |
| mab | 784 |
| speed | 784 |
| believed | 784 |
| give | 784 |
| reproductive | 783 |
| scan | 783 |
| tuberculosis | 783 |
| adapted | 783 |
| filter | 782 |
| marked | 781 |
| restricted | 779 |
| minimize | 778 |
| explored | 777 |
| phosphorylation | 777 |
| evaluating | 777 |
| transcriptase | 777 |
| deficiency | 776 |
| immunosuppressive | 775 |
| ma | 774 |
| blockers | 774 |
| updated | 773 |
| pool | 772 |
| pathophysiology | 772 |
| subset | 771 |
| subjected | 770 |
| front | 770 |
| im | 769 |
| sp | 769 |
| pd | 768 |
| experiment | 768 |
| activates | 768 |
| operating | 767 |
| analytical | 767 |
| derivatives | 767 |
| immunomodulatory | 767 |
| gamma | 766 |
| providers | 766 |
| analyze | 766 |
| attributed | 766 |
| arabia | 765 |
| submitted | 765 |
| contagious | 764 |
| alcohol | 764 |
| edema | 762 |
| stored | 762 |
| adopted | 762 |
| referred | 762 |
| sign | 760 |
| kinetics | 760 |
| radiological | 759 |
| improving | 759 |
| initiated | 758 |
| cytotoxic | 757 |
| antimicrobial | 757 |
| mabs | 756 |
| transmissibility | 756 |
| physiological | 756 |
| receive | 756 |
| plan | 755 |
| subunits | 755 |
| yield | 754 |
| inducing | 754 |
| perceived | 754 |
| birth | 754 |
| cr | 753 |
| seroconversion | 752 |
| prophylactic | 748 |
| balance | 748 |
| downstream | 748 |
| medication | 748 |
| news | 748 |
| worse | 747 |
| tube | 744 |
| north | 744 |
| monocyte | 743 |
| trend | 743 |
| decisions | 743 |
| limiting | 742 |
| ischemic | 742 |
| modulation | 741 |
| promotes | 741 |
| variability | 741 |
| purpose | 740 |
| recruitment | 739 |
| predicting | 739 |
| concerning | 738 |
| rise | 738 |
| determinants | 737 |
| arg | 737 |
| matter | 737 |
| synthesized | 736 |
| reagents | 736 |
| immunized | 736 |
| coughing | 735 |
| genus | 735 |
| multicenter | 735 |
| black | 735 |
| parts | 734 |
| listed | 734 |
| elements | 734 |
| scenario | 734 |
| magnetic | 733 |
| coli | 733 |
| excessive | 732 |
| pangolin | 731 |
| unlikely | 731 |
| glu | 731 |
| actual | 730 |
| independently | 730 |
| explained | 730 |
| vectors | 730 |
| preparedness | 730 |
| producing | 730 |
| hypoxia | 729 |
| zika | 729 |
| invasion | 729 |
| adjuvant | 729 |
| du | 729 |
| chains | 729 |
| determining | 728 |
| alterations | 727 |
| package | 727 |
| partially | 726 |
| put | 726 |
| trigger | 726 |
| adaptation | 725 |
| shortness | 724 |
| chemokine | 723 |
| technical | 723 |
| bp | 723 |
| effort | 722 |
| confirmation | 722 |
| examine | 722 |
| statistics | 722 |
| malaria | 721 |
| scientists | 721 |
| epidemiologic | 721 |
| med | 720 |
| codon | 720 |
| hands | 719 |
| introduced | 719 |
| arbidol | 719 |
| plants | 718 |
| serologic | 717 |
| missing | 717 |
| bovine | 716 |
| accumulation | 716 |
| rule | 715 |
| believe | 715 |
| determination | 715 |
| kb | 714 |
| soon | 714 |
| accessory | 714 |
| affects | 714 |
| cxcl | 713 |
| devices | 713 |
| raised | 713 |
| asian | 712 |
| impacts | 712 |
| cycles | 712 |
| appearance | 711 |
| visit | 710 |
| cas | 710 |
| lowest | 709 |
| gi | 709 |
| stimulation | 709 |
| pharmacological | 708 |
| considerable | 708 |
| breathing | 707 |
| planning | 707 |
| percent | 706 |
| viable | 705 |
| monkeys | 705 |
| grade | 705 |
| come | 705 |
| underwent | 705 |
| forward | 705 |
| fear | 704 |
| measurements | 704 |
| virological | 702 |
| accordance | 702 |
| databases | 702 |
| reasonable | 702 |
| completed | 702 |
| zhou | 702 |
| neutral | 702 |
| discussion | 701 |
| toxic | 701 |
| demand | 701 |
| cleaved | 700 |
| get | 700 |
| electronic | 700 |
| apart | 700 |
| rs | 699 |
| atoms | 698 |
| file | 698 |
| fight | 697 |
| onto | 697 |
| transgenic | 697 |
| offer | 697 |
| asp | 696 |
| cat | 696 |
| virology | 696 |
| delay | 696 |
| ones | 696 |
| substitution | 696 |
| prominent | 695 |
| growing | 695 |
| causative | 694 |
| regulate | 694 |
| decline | 693 |
| regulates | 693 |
| simultaneously | 692 |
| interacts | 692 |
| timely | 692 |
| nanoparticles | 691 |
| ncbi | 690 |
| pigs | 690 |
| cap | 690 |
| power | 690 |
| weak | 690 |
| uncertainty | 690 |
| inc | 690 |
| antibiotics | 689 |
| mesenchymal | 689 |
| instructions | 689 |
| input | 689 |
| conservation | 689 |
| mellitus | 689 |
| ferrets | 689 |
| cathepsin | 689 |
| assumed | 688 |
| contributes | 688 |
| wildlife | 687 |
| mapping | 687 |
| advantage | 687 |
| si | 685 |
| consequence | 685 |
| nonstructural | 685 |
| sequenced | 685 |
| mediates | 684 |
| lacking | 684 |
| restrictions | 684 |
| dysregulation | 684 |
| strict | 684 |
| trends | 683 |
| quantification | 683 |
| rats | 682 |
| becomes | 682 |
| relevance | 682 |
| subsets | 682 |
| cities | 681 |
| constructed | 681 |
| myalgia | 681 |
| progressive | 681 |
| interferons | 680 |
| cohorts | 680 |
| concept | 679 |
| institutions | 679 |
| enable | 679 |
| highlight | 679 |
| board | 678 |
| roche | 678 |
| gut | 677 |
| hcw | 677 |
| composed | 676 |
| categories | 676 |
| tm | 676 |
| copd | 676 |
| hemorrhagic | 675 |
| timing | 675 |
| reviews | 674 |
| restriction | 674 |
| inoculation | 674 |
| insight | 674 |
| rest | 674 |
| massive | 674 |
| dogs | 674 |
| highlights | 673 |
| kda | 673 |
| communities | 673 |
| born | 673 |
| transcriptional | 672 |
| respective | 672 |
| tomography | 672 |
| parameter | 672 |
| supportive | 672 |
| probes | 671 |
| injection | 671 |
| native | 670 |
| handling | 669 |
| students | 669 |
| differ | 668 |
| zu | 668 |
| frequencies | 667 |
| supports | 667 |
| questionnaire | 667 |
| practical | 667 |
| choice | 667 |
| lys | 667 |
| modification | 666 |
| category | 666 |
| solutions | 666 |
| behaviors | 666 |
| aa | 666 |
| ccl | 666 |
| mhc | 665 |
| requirements | 665 |
| create | 664 |